ES  -  EN
  • The facility is under SEZ with a total area of 24,315 square meters.
  • It is capable to manufacture injectable and oral solid dosage for USA, Europe and ROW markets.
  • Site capacity:
    • Orals sold dosages: 2 billion
    • Injectable: 44 million
  • The facility was commissioned in 2008 and was acquired by Insud Pharma in 2024.

Address: 20/21, Pharmez, The Pharmaceutical Special Economic Zone, N H No. 8 A, Tal Sanand, Ahmedabad, Gujarat 382213, India

Telephone: +91 75730 00774

Email: comunicacion@insudpharma.com